Early Remdesivir Tracked with About 25 Percent Lower Death Risk in Hospitalized Patients with Kidney Disease
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Thu, 3 September 2026
What it is about
Who published it, and when
How it spread - 1 original report
Thu, 3 September 2026
1 report- medicaldaily.com15:00first to report
A claims-based study of 27,000 hospitalized COVID patients links early remdesivir to lower 28-day death risk. Gilead helped conduct the research.